Zhiyong Li, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 315 N Shiloh Rd, Suite 101, Garland, TX 75042 Phone: 972-487-8866 Fax: 972-487-8190 |
Saira M Hassan, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 315 N Shiloh Rd, Suite 101, Garland, TX 75042 Phone: 972-487-8866 Fax: 972-487-8190 |
Dr. Sashidhar Narapa Reddy, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 777 Walter Reed Blvd, #201, Garland, TX 75042 Phone: 972-272-3417 Fax: 972-487-1749 |
News Archive
An interesting new study reports that vaccine hesitancy in the UK is driven not, as is commonly thought, by the so-called ‘infodemic' of misinformation that has characterized much public messaging during the COVID-19 pandemic. Instead, the personality of the individual, the ability to trust scientific and government leadership, political affiliations, and openness relative to the process of vaccine development was found to be key in the development of this attitude.
At present the current limit for abortions is 24 weeks, but a survey of 1,000 GPs by Marie Stopes International, found 65 per cent thought the current 24-week abortion limit should be cut; of these, 62 per cent said the upper limit should remain within 20 to 23 weeks.
Centice Corporation, a pioneer in chemical verification and identification using Raman Spectroscopy and computational sensor technology, announced today the availability of an integration and solutions platform for the application of Computational Raman Spectroscopy to satisfy technology needs in process manufacturing, healthcare, public safety and materials science.
Rhonda Ellison was six months pregnant when she and her husband, James Gaines, got the kind of news all parents dread going into an ultrasound: something was wrong with their baby. They needed to go to the Children's Heart Center at Golisano Children's Hospital.
miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, announced today the formation of the company's world renowned Scientific Advisory Board (SAB). The SAB was established to provide miRagen with valuable guidance in developing an extensive pipeline of microRNA-based drugs and is comprised of leaders who are internationally recognized experts in their respective fields.
› Verified 1 days ago